The biotech behemoth is now the largest of over 200 biotech companies in South San Francisco, which contains over 11.5M SF and counting of biotech space, according to the city website.
BioMed Realty is well into construction of its 1.4M SF Gateway of Pacific development, with the 479K SF first phase already leased to AbbVie. Phase 3 Real Estate Partners’ recently opened the 21-floor north tower of its 715K SF Genesis project. Kilroy Realty Corp. is beginning construction on 630K SF across three buildings at Oyster Point, the San Francisco Business Times reports.
1. Who are the major development players currently building life sciences campuses, facilities, and buildings on the Peninsula?
2. What is the relationship like between the life sciences and biotech companies (from startup to IPO) and CRE developers and investors?
3. Is there adequate demand in place for the vast amount of supply under development or proposed?
4. What are the benefits (and challenges) of developing CRE for the life sciences industry?
5. What other neighborhoods across the Bay Area can support and sustain life sciences development of this magnitude?